Why Arafura, Challenger, Nanosonics, and TPG shares are storming higher today

These shares are having a strong session on Thursday. But why?

| More on:
three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a strong session on Thursday. In afternoon trade, the benchmark index is up 1% to 7,905 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are storming higher:

Arafura Rare Earths Ltd (ASX: ARU)

The Arafura Rare Earths share price is up 12% to 20.7 cents. Investors have been buying this rare earths developer's shares after it announced a major offtake agreement. Arafura revealed that it has secured a binding offtake agreement with global metals and minerals trader Traxys Europe SA. This will see it supply at least 100 tonnes per annum (tpa) of neodymium-praseodymium (NdPr) oxide to Traxys over five years. It also has the option to increase the volume up to 300 tpa. This means that Arafura now has 66% of its offtake goal secured.

Challenger Ltd (ASX: CGF)

The Challenger share price is up almost 7% to $5.98. This may have been driven by a bullish broker note out of Barrenjoey this morning. According to the note, the broker has upgraded Challenger's shares to a buy rating (from hold) with an improved price target of $7.00 (from $6.65). This implies potential upside of 17% from current levels over the next 12 months.

Nanosonics Ltd (ASX: NAN)

The Nanosonics share price is up 14% to $4.98. This morning, this infection prevention company revealed that it has received De Novo clearance from the U.S. Food and Drug Administration (FDA) for its latest innovation, the CORIS system. CORIS is a novel technology designed to reduce infection risk and enhance patient safety. It does this by delivering improved cleaning outcomes for flexible endoscopes. This includes the complex channels of endoscopes which are prone to biofilm build up. Nanosonics' CEO, Michael Kavanagh, said: "CORIS represents a significant opportunity for the organisation and the FDA de novo clearance marks a key milestone for the Company and an important step in bringing this much needed innovation to market."

TPG Telecom Ltd (ASX: TPG)

The TPG Telecom share price is up 5% to $4.78. This follows news that the ACCC will not oppose the sale of TPG's fibre network infrastructure assets and Enterprise, Government and Wholesale fixed operations to Vocus Group for an enterprise value of $5,250 million. TPG chief executive, Iñaki Berroeta, said: "We are pleased to have passed this important regulatory milestone and are now focussed on completing the transaction later this year. This transaction forms an important part of our strategy to simplify our business and accelerate and increase the streamlining of our operating structure and cost base."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Nanosonics. The Motley Fool Australia has positions in and has recommended Nanosonics. The Motley Fool Australia has recommended Challenger. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today

These shares are ending the week on a high. But why?

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy Thursday for ASX investors.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why BHP, DroneShield, Lotus Resources, and Nuix shares are pushing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day for the ASX.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why 4DMedical, Dateline, Predictive Discovery, and Wildcat shares are racing higher

These shares are having a good session on hump day. But why?

Read more »